JM Innovations



Iowa Ag News Headlines
Iowa Firm Licenses Additional Anti-Zika Virus Compounds
Iowa Ag Connection - 02/17/2017

Spotlight Innovation Inc., Urbandale, Iowa, announced that it has entered into a second license agreement with the Florida State University Research Foundation (FSURF) for the development and commercialization of additional anti-Zika virus compounds. As with the initial license agreement, this agreement grants to Spotlight Innovation exclusive, worldwide rights to develop and commercialize certain compounds for the treatment of viral infections, including Zika virus infection.

John Krohn, Spotlight Innovation's president and chief operating officer, said, "This new Zika-focused license agreement, which complements our first agreement, affirms our ongoing commitment to develop pioneering treatments for emerging diseases such as Zika virus infection."

Spotlight Innovation identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. To find and evaluate unique opportunities, it leverages its extensive relationships with leading scientists, academic institutions and other sources. It provides value-added development capability to accelerate development progress. When scientifically significant benchmarks have been achieved, it will endeavor to partner with proven market leaders via sale, out-license or strategic alliance.

Send this article to a friend


Other Iowa Headlines
International Protein Sires
U.S. Custom Harvesters, Inc.
Copyright 2017 - USAgNet.com. All Rights Reserved.